Navigation Links
Even tiny breast tumors can be aggressive and may require maximum therapy
Date:12/17/2007

fueling growth, and cancer that is ER/PR+ is considered the least aggressive of the three categories. Generally, studies have shown that in all patients diagnosed with breast cancer, 15 to 20 percent of breast cancers are HER2+ and about 10 to 15 percent are triple negative.

Patients were followed for an average of almost three years, and so far researchers have data on all patients with HER2+ and triple negative cancers and on 219 women with HER2 negative/ER/PR+ cancer. Researchers found that:

  • There were many more grade 2 and grade 3 tumors in women with the two rarer subtypes 92 percent in HER2+ cancer and 91 percent in triple negative cancer compared to HER2 negative/ER/PR+ cancer (36 percent). Tumors are graded 1-3, and higher grade tumors are more likely to grow faster and be more difficult to treat than lower grade tumors.
  • Cancer came back more frequently in HER2+ tumors (7.4 percent of patients relapsed) and triple negative cancers (12.5 percent), compared to HER2 negative/ER/PR+ cancer (1.3 percent).
  • Although the overall outcome of these small, lymph-node-negative tumors was excellent (overall survival 97.4 percent, disease free survival 95.1 percent), these outcomes were different in the three subgroups studied. The death rate was higher in triple negative breast cancer: there was one death in the 24 patients with triple negative tumors, none in the HER2+ group of 27 women, and one death related to relapse in 219 women with HER2 negative/ER/PR+ cancer.

Although only small numbers of women have the rarer cancer subtypes included in this study, the findings suggest that women with HER2+ and triple negative tumors should receive as much treatment as possible in order to prevent cancer relapse, Dr. Amar says. Researchers found that only 35 percent of women with triple negative cancer were treated with adjuvant chemotherapy (chemotherapy after surgery) despite the higher grade of the tumor
'/>"/>

Contact: Paul Scotti
scotti.paul@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...ains financial implications of SSDI benefits, onli...ple with disabilities. , ...ng how to move forward after a diagnosis of a long...portant that individuals do as much as they can to... http://www.allsup.com/ [Allsup], which represent...
(Date:8/28/2008)...ntia led to daytime tiredness, symptoms of depress...s) -- Older adults who live with and provide direc...have significantly worse sleep than other older ad...ed 31 caregivers and 102 noncaregivers, ages 60 to...ght than non-caregivers and took about 10 minutes ...
(Date:8/28/2008)...RNewswire/ -- The 2008 European,Hemodialysis Emerg...ense,Medical in recognition of its pioneering Reds...sense detects the loss of blood during hemodialysi...device consists of an alarm and a sensor patch. Th...ic technology that sends signals,alerting caregive...
(Date:8/28/2008)...Northeast region with more hires,planned throughou..., Aug. 28 /PRNewswire-USNewswire/ -- The Pennsylva...afety Liaison for the,Northeast region to help hea... Patient Safety Reporting System (PA-PSRS) improve... year in focus groups with Pennsylvania Patient Sa...
Breaking Medicine News(10 mins):Health News:Social Security Disability Can Be Key to Financial Future 2Health News:Social Security Disability Can Be Key to Financial Future 3Health News:Social Security Disability Can Be Key to Financial Future 4Health News:Social Security Disability Can Be Key to Financial Future 5Health News:Social Security Disability Can Be Key to Financial Future 6Health News:Older Caregivers Prone to Worse Sleep Patterns 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 3Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...ce of the deadly bird flu infection has been confi...opean Union. Reassurance steps have been initiated...on in dead swans, last week . // The EU confirmed...boratory in Britain after a first analysis by loca...
...e Day warning has been issued by Singapore cardiol...is likely to increase risk of heart attack in othe... National University Hospital (NUH) in Singapore, ...red to confirm what men have long suspected - that...
...vers of coffee, it as been found in a study that d...e catch is that consumption should be moderate. It... type-2 diabetes in younger and middle-aged women....inked drinking more than two cups of coffee or tea...
... scientists are of the opinion that older adults w...nd heart disease. // The researchers at the Unive... high risk than those without asthma to suffer chr...abetes, arthritis, osteoporosis, stroke, and canc...
Other Medicine News:
(Date:8/27/2008).../-, - Oralair(R) Grasses 3...odynamic Study Conducted in an Allergen Challenge ...ositive results of a new study,conducted in an All...air(R) Grasses included 86 adult patients exposed ... durations: 1 week, 1 month,2 and 4 months withou...
(Date:8/27/2008)...m BLISS-52 trial, expected by mid-2009 - - Data f...ll 2009 -, ROCKVILLE, Md., Aug. 27 /PRNewswire-Fi...HGSI ) today announced it has completed enrollment... pivotal Phase 3,randomized clinical trials of Lym...ystemic lupus erythematosus (SLE). Belimumab is be...
(Date:8/26/2008)...a from landmark SYNTAX clinical trial, NATICK, Ma...ntific,Corporation (NYSE: BSX ) today announced t...s announcements at the European Society of Cardiol...ptember 3 in Munich, Germany., The Company plans ...hich compares percutaneous coronary intervention (...
(Date:8/26/2008)...ewswire/ -- Semafore Pharmaceuticals Inc.,presente...rgeted Therapies,in Cancer in Washington, D.C., an...ase inhibitors that demonstrate significant antica...d proprietary molecular scaffold has been develope...sign of pan-PI3 kinase inhibitors,as well as isofo...
Breaking Medicine Technology:Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Raydiance collaborates with Rutgers MTF to develop innovative tissue processing approaches 1269 1Raydiance collaborates with Rutgers MTF to develop innovative tissue processing approaches 1269 2Novo Nordisk Inc Announces Exclusive Agreement With Sciele Pharma Inc to Market Prandin 28R 29 1850 1Novo Nordisk Inc Announces Exclusive Agreement With Sciele Pharma Inc to Market Prandin 28R 29 1850 2Novo Nordisk Inc Announces Exclusive Agreement With Sciele Pharma Inc to Market Prandin 28R 29 1850 3Eating disorders in adolescents 6616 1Eating disorders in adolescents 6616 2Eating disorders in adolescents 6616 3Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program 6611 1Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program 6611 2Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program 6611 3Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program 6611 4Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program 6611 5
...26, 2007 - Study results show,that elevated lipopr...diovascular-specific inflammatory enzyme associate...ck and stroke, is,especially predictive of heart d...e--a serious medical condition that affects nearly...sented yesterday,at the American College of Cardio...
...wswire/ -- Cleveland Clinic,researchers today repo... density lipoprotein cholesterol (HDL) or the "goo...progression of,plaque buildup in the coronary arte...en Nissen, M.D., Chairman of Cardiovascular Medici...is clinical trial, will,present the study on Monda...
Other Medicine Technology:Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 2Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 4
The ENDO MINI-RETRACT™ 5 mm instrument has application in a variety of gynecologic, abdominal, urologic, thoracic and endoscopic procedures for temporary retraction of tissue and small tubular
...NDO PADDLE RETRACT™ 12 mm instrument has app...logic,thoracic, colorectal and other endoscopic pr... the bowel, stomach, or liver. , ,The ENDO PADDLE...tractor at the distal end of the instrument and is...
The Featured Products are kept in stock at Mediflex and are offered as 1-piece or modular in regular or extra long lengths. All come equipped with insulation, flush ports, rotating shafts, ratchets (
...ffering of single-use instruments on the market., ...engths for Bariatric Surgery. , Dual action tips ...vers the pivot points to reduce the chance of alte... eliminates gapping at connection and the need for...
Medicine Products: